Treatment of women with PCOS using an angiotensin-converting enzyme (ACE) inhibitor led to a substantial reduction in HTN and serum testosterone, indicating that RAS blockade may inhibit androgen synthesis [44,45]. This evidence concerns the gene ACE and polycystic ovary syndrome.